Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody

Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody

Abstract Background Individuals with end-stage kidney disease (ESKD) on dialysis are vulnerable to contracting COVID-19 infection, with mortality as high as 31 % in this group. Population demographics in the UAE are dissimilar to many other countries and data on antibody responses to COVID-19 is als...

Full description

Bibliographic Details
Main Authors: Wasim Ahmed, Ali Abdul Kareem Al Obaidli, Princy Joseph, Edward R. Smith, Ayaz Ahmad Khan, Siddiq Anwar, Thangavelu Chandrasekar, Ayman Kamal Al Madani, Hormazdiar Dara Dastoor, Imran Zahid, Freddie Agbayani Costales, Yousef Abdul Rahim Boobes, Fatima Al Kindi, Salah Eldin Khalil Issa, Mohamed H. Hassan, Abraham George, Stephen Geoffrey Holt
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Nephrology
Subjects:
COVID-19
End stage kidney disease
Dialysis
IgG antibody
Mortality
Screening
Online Access:https://doi.org/10.1186/s12882-021-02378-y

Internet

https://doi.org/10.1186/s12882-021-02378-y

Similar Items